            &         (1)   &         (2)   \\
treatment1  &    -234.951** &     -34.495   \\
            &    (86.332)   &    (46.137)   \\
sale_fieldsara_bsl&     516.876***&      88.955   \\
            &   (129.577)   &    (62.228)   \\
trtXsale_fieldsara_bsl&    -197.550   &      36.959   \\
            &   (157.278)   &    (67.754)   \\
h_d_suplag1_bsl&     100.709   &      67.004   \\
            &   (150.466)   &    (45.916)   \\
h_d_suplag2_bsl&     250.861   &     -22.288   \\
            &   (124.158)   &    (43.677)   \\
h_d_suplag3_bsl&     386.348*  &      13.120   \\
            &   (151.886)   &    (32.794)   \\
h_d_suplag4_bsl&    -170.603   &     -29.553   \\
            &    (85.550)   &    (23.437)   \\
h_d_suplag5_bsl&    -124.845   &     -72.558*  \\
            &   (151.715)   &    (30.479)   \\
h_d_suplag6_bsl&     636.816** &     276.694*  \\
            &   (216.313)   &   (102.098)   \\
_cons       &     537.746***&     -20.607   \\
            &   (100.674)   &    (36.707)   \\
p-value conv.&       0.010   &       0.459   \\
p-value RI  &           1   &           1   \\
Control mean&       810.4   &        19.0   \\
Nb replications&           1   &           1   \\
Baseline outcome&          no   &          no   \\
Observations&         515   &         515   \\
